MVK Gene Porokeratosis Type 3 Disseminated Superficial Actinic Genetic Test sale cost 4400 AED
CA2 Gene Osteopetrosis Autosomal Recessive Type 3 Genetic Test sale cost 4400 AED CA2 Gene Osteopetrosis Autosomal Recessive Type 3 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CTSK Gene Pycnodysostosis Genetic Test sale cost 4400 AED CTSK Gene Pycnodysostosis Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

MVK Gene Porokeratosis Type 3 Disseminated Superficial Actinic Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MVK Gene Porokeratosis Type 3 Disseminated Superficial Actinic Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the MVK gene associated with Porokeratosis Type 3, also known as Disseminated Superficial Actinic Porokeratosis (DSAP). Porokeratosis is a group of rare skin disorders characterized by the development of abnormal keratinization leading to distinctive ring-like plaques on the skin. DSAP, in particular, is exacerbated by sun exposure and tends to appear in adulthood.

This genetic test plays a crucial role in the accurate diagnosis of DSAP, enabling healthcare providers to tailor specific treatment and management plans for affected individuals. It involves analyzing the patient’s DNA to detect mutations in the MVK gene, which have been linked to the condition. Early diagnosis through genetic testing can significantly improve the quality of life for individuals with DSAP by providing insights into the condition’s progression, potential complications, and effective preventive measures against excessive sun exposure.

The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, reliable results. By choosing DNA Labs UAE for the MVK Gene Porokeratosis Type 3 Disseminated Superficial Actinic Genetic Test, patients can expect a comprehensive evaluation guided by genetic experts in a supportive and informative environment.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MVK Gene Porokeratosis Type 3 Disseminated Superficial Actinic Genetic Test

Introduction

DSAP is a rare skin disorder characterized by multiple small, raised, and scaly patches on sun-exposed areas of the skin. It is caused by mutations in the MVK gene, which is responsible for encoding the enzyme mevalonate kinase. This enzyme plays a role in the production of cholesterol and other essential molecules in the body.

Test Details

The NGS Genetic Test for MVK Gene Porokeratosis type 3, disseminated superficial actinic (DSAP) is a genetic test that utilizes Next-Generation Sequencing (NGS) technology to analyze the MVK gene for specific mutations associated with DSAP. The test aims to identify specific mutations in the MVK gene that are known to be associated with DSAP.

Components

  • Test Name: MVK Gene Porokeratosis type 3 disseminated superficial actinic Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Osteology Dermatology Immunology Disorders
  • Doctor: Dermatologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for MVK Gene Porokeratosis type 3, disseminated superficial actinic NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MVK Gene Porokeratosis type 3, disseminated superficial actinic NGS Genetic DNA Test gene MVK.

Test Process

The test typically involves collecting a blood or saliva sample from the patient, which is then sent to a laboratory for analysis. The laboratory uses NGS technology to sequence the MVK gene and identify any potential mutations.

Benefits of Genetic Testing

Genetic testing for MVK Gene Porokeratosis type 3, DSAP can be useful for individuals with suspected or confirmed DSAP, as well as their family members. It can provide information about the genetic basis of the condition, aid in genetic counseling, and help guide treatment decisions.

Interpretation and Genetic Counseling

It is important to note that genetic testing is typically performed by healthcare professionals with expertise in genetics. The results of the test should be interpreted in the context of the patient’s clinical presentation and family history, and genetic counseling may be recommended to discuss the implications of the test results.

Test Name MVK Gene Porokeratosis type 3 disseminated superficial actinic Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MVK Gene Porokeratosis type 3, disseminated superficial actinic NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MVK Gene Porokeratosis type 3, disseminated superficial actinic NGS Genetic DNA Test gene MVK
Test Details

The NGS Genetic Test for MVK Gene Porokeratosis type 3, disseminated superficial actinic (DSAP) is a genetic test that utilizes Next-Generation Sequencing (NGS) technology to analyze the MVK gene for specific mutations associated with DSAP.

DSAP is a rare skin disorder characterized by multiple small, raised, and scaly patches on sun-exposed areas of the skin. It is caused by mutations in the MVK gene, which is responsible for encoding the enzyme mevalonate kinase. This enzyme plays a role in the production of cholesterol and other essential molecules in the body.

The NGS Genetic Test for MVK Gene Porokeratosis type 3 aims to identify specific mutations in the MVK gene that are known to be associated with DSAP. By analyzing the patient’s DNA sample, the test can determine whether there are any pathogenic variants or mutations in the MVK gene.

The test typically involves collecting a blood or saliva sample from the patient, which is then sent to a laboratory for analysis. The laboratory uses NGS technology to sequence the MVK gene and identify any potential mutations. The results of the test can help confirm a diagnosis of DSAP and provide information about the specific genetic variant involved.

Genetic testing for MVK Gene Porokeratosis type 3, DSAP can be useful for individuals with suspected or confirmed DSAP, as well as their family members. It can provide information about the genetic basis of the condition, aid in genetic counseling, and help guide treatment decisions.

It is important to note that genetic testing is typically performed by healthcare professionals with expertise in genetics. The results of the test should be interpreted in the context of the patient’s clinical presentation and family history, and genetic counseling may be recommended to discuss the implications of the test results.

SKU: TEST-3219 Category:

Related products